Keyphrases
Spliceosome-mediated RNA Trans-splicing
100%
Exon 10
100%
FTDP-17
100%
MAPT mutation
100%
Mis-splicing
100%
Trans-splicing
60%
Cis-splicing
30%
Alternative Splicing
20%
RNA Molecules
20%
Exonic Splicing Enhancer
20%
Therapeutic Strategies
10%
Neurodegenerative Diseases
10%
Minigene
10%
Cis-acting
10%
RNA Splicing
10%
Frontotemporal Dementia with Parkinsonism Linked to Chromosome 17
10%
COS Cells
10%
Intraneuronal
10%
Pathogenic mutations
10%
Pre-mRNA
10%
Choice Method
10%
In Cis
10%
5′ Splice Site
10%
Co-transfection
10%
Stem-loop
10%
Exonic
10%
Intronic mutation
10%
Tau Protein
10%
MAPT Gene
10%
Biochemistry, Genetics and Molecular Biology
Exon
100%
Tau
100%
Spliceosome
100%
Trans Splicing
100%
RNA
30%
RNA Splicing
30%
Alternative Splicing
20%
Enhancer Region
20%
Messenger RNA
20%
Precursor mRNA
10%
Transfection
10%
Intron
10%
Minigene
10%
Reprogramming
10%
Tau Protein
10%
Chromosome 17
10%
COS Cells
10%
Stem-Loop
10%
Neuroscience
Exon
100%
Trans-Splicing
100%
Spliceosome
100%
RNA Splicing
30%
Alternative Splicing
20%
Enhancer Region
20%
Messenger RNA
20%
Transfection
10%
Neurodegenerative Disorder
10%
Parkinsonism
10%
Chromosome 17
10%
Tau Protein
10%
Intron
10%
Frontotemporal Dementia
10%
COS Cells
10%
Reprogramming
10%
Precursor mRNA
10%
Stem-Loop
10%
Immunology and Microbiology
Spliceosome
100%
Trans-Splicing
100%
Exon
100%
RNA Splicing
30%
Enhancer Region
20%
Alternative RNA Splicing
20%
Genetic Transfection
10%
Intron
10%
Chromosome 17
10%